Trials / Completed
CompletedNCT01010152
Comparative Bioavailability Study of Codeine Sulfate
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Comparative Bioavailability Study fo Codeine 30 mg Tablets and Tylenol #3 Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Codeine Sulfate | 30 mg Tablet |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2009-11-09
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01010152. Inclusion in this directory is not an endorsement.